Oak HC/FT invests in healthcare focused tech-enabled service businesses. We are investing out of our fourth fund, which is $1.4B, and have $3.3B in assets under management. Our portfolio includes +35 healthcare companies and we invest at all stages (seed through buyout).

Oak HC/FT is a venture and growth equity investment firm that focuses on healthcare information services and financial service technology. The firm focuses on driving transformation in these industries by providing entrepreneurs and companies with strategic counsel, board-level participation, and access to our extensive network of industry leaders. Oak HC/FT partners are peerless in delivering returns for investors and growing innovative businesses. Over the past decade, the partners at Oak HC/FT have had 20 realizations with 6 companies achieving valuations in excess of $1 billion. Oak HC/FT is led by the Healthcare and FinTech team of Oak Investment Partners as part of Oak’s strategy to develop sector-specific funds and continue its legacy of building best-in-class businesses.

Jvion helps healthcare systems and providers prevent harm and lower costs through its AI-enabled prescriptive analytics solution. An industry first, the Jvion Machine™ goes beyond simple predictive analytics and machine learning to identify patients on a trajectory to becoming high risk and for whom intervention will likely be successful. Jvion determines the interventions that will more effectively reduce risk and enable clinical action. And it accelerates time to value by leveraging established patient-level intelligence to drive engagement across hospitals, populations, and patients.

Preventable harm is preventable. Jvion helps healthcare systems prevent patient harm and associated costs by enabling clinical staff to focus attention, resources, and individualized interventions on patients whose outcomes can be improved. Unlike traditional AI and predictive analytic solutions that merely identify high-risk patients and cause alarm fatigue, Jvion pinpoints the impactable patients who are on a risk trajectory that can be changed and provides the patient-specific recommendations that will drive to a better outcome. The Jvion Machine™ is a combination of Eigen-based mathematics, dataset of more than 16 million patients, and software that can be quickly applied to any of 50 preventable harm vectors (such as sepsis, readmissions, falls, avoidable ER visits, and pressure injuries) without the need to create new models or to have perfect data. As the leader in prescriptive analytics for preventable harm, Jvion has proven effective in clinical settings for nearly a decade, with hospitals reporting average reductions of 30% in preventable harm incidents and avoidable cost savings of $6.3 million a year.